Why Is Neurocrine Biosciences, Inc. (NBIX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
Neurocrine Biosciences, Inc. (NBIX)
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
neurocrine.com/about-us/webcasts-presentations
Company Research
Source: Yahoo! Finance
2027 and 2032, reaching an estimated $4.8 trillion in 2023. (Source: Centers for Medicare and Medicaid Services) The primary trends to watch in the healthcare industry this year are the pharmaceutical, medical equipment and supplies, robotics, biotechnology, and neurodegenerative illnesses sub-spaces, with a focus on the emergence and development of glucagon-like Peptide-1 agonists (GLP-1s) in the pharmaceutical industry. (Source: World Health Organization report) Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) revenue growth rate is 27.13%, driven primarily by increased patient demand for INGREZZA across both Tardive Dyskinesia (TD) and Huntington's Disease Chorea indications. (Source: Neurocrine Biosciences, Inc.'s Q3 2024 earnings report) Street analysts hold a consensus Strong Buy rating on the stock, with an average 12-month price target of $166.53, representing a 35.07% upside potential. (Source: Street analysts' consensus rating and price target) Neurocrine Biosciences, In
Show less
Read more
Impact Snapshot
Event Time:
NBIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBIX alerts
High impacting Neurocrine Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
NBIX
News
- Why Neurocrine Biosciences (NBIX) Is the Most Profitable Pharmaceutical Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences to Participate at Investor Conferences in DecemberPR Newswire
- Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Neurocrine Biosciences' (NASDAQ:NBIX) Strong Earnings Are Of Good Quality [Yahoo! Finance]Yahoo! Finance
NBIX
Earnings
- 10/30/24 - Beat
NBIX
Sec Filings
- 12/3/24 - Form 4
- 11/29/24 - Form 144
- 11/12/24 - Form 4
- NBIX's page on the SEC website